Trials / Completed
CompletedNCT01050374
Safety and Efficacy of Drug Combinations Against Schistosomiasis
Gaps in Helminth Control: Safety and Efficacy of Drug Combinations. Praziquantel Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 650 (estimated)
- Sponsor
- DBL -Institute for Health Research and Development · Academic / Other
- Sex
- All
- Age
- 1 Year – 15 Years
- Healthy volunteers
- Not accepted
Summary
This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of MBD in combination with PZQ in the treatment of SCH and STH in children aged 1-15 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | albendazole + praziquantel | albendazole (400 mg one dose) + praziquantel (40 mg/kg body weight) |
| DRUG | mebendazole + praziquantel | mebendazole (500 mg one dose) + praziquantel (40 mg/kg body weight) |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2010-01-15
- Last updated
- 2010-01-15
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT01050374. Inclusion in this directory is not an endorsement.